Author: Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
The History of Psychopharmacology and the CINP as Told in Autobiography
Author: The History of Psychopharmacology and the Cinp - As Told in Autobiography
Author: Thomas A. BanPublisher: Collegium Internationale Neuro-Psychopharmacologic
ISBN: 9789634081814
Category :
Languages : en
Pages : 376
Book Description
This series covers in autobiographical accounts the first fifty years in the history of neuropsychopharmacology. The autobiographies in Volume I, (The Rise of Psychopharmacology and the Story of CINP) are from psychopharmacologists who began their professional careers in the 1950s and 1960s; in Volume II (The Triumph of Psychopharmacology and the Story of CINP), from those who started in the 1970s; in Volume III (From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP), who started in the 1980s; and in Volume IV (Reflections on Twentieth-Century Psychopharmacology), who started in the 1990s. At the core of each volume are personal accounts in which the contributions of the scientists, are at the center of the reflections, but also include several sections in which the reflections are focused on the mainstream of events, particular areas of research, individuals and organizations. The series was the extension of an effort by CINP’s History Committee, during the chairmanship of Tom Ban, to document both the history of the College and the enire field. It was co-edited by Ban, David Healy and Edward Shorter. Its publication was supported by the College primarily from non-restricted publication grants received from Pierre Fabre, Janssen Pharmaceutica and Research Foundation,Inc., and Janssen Phamaceutica International in Collaboration with Organon International.
From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP, as Told in Autobiography
Author: Thomas A. BanPublisher: Collegium Internationale Neuro-Psychopharmacologic
ISBN:
Category : Neuropsychopharmacology
Languages : en
Pages : 416
Book Description
This series covers in autobiographical accounts the first fifty years in the history of neuropsychopharmacology. The autobiographies in Volume I, (The Rise of Psychopharmacology and the Story of CINP) are from psychopharmacologists who began their professional careers in the 1950s and 1960s; in Volume II (The Triumph of Psychopharmacology and the Story of CINP), from those who started in the 1970s; in Volume III (From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP), who started in the 1980s; and in Volume IV (Reflections on Twentieth-Century Psychopharmacology), who started in the 1990s. At the core of each volume are personal accounts in which the contributions of the scientists, are at the center of the reflections, but also include several sections in which the reflections are focused on the mainstream of events, particular areas of research, individuals and organizations. The series was the extension of an effort by CINP's History Committee, during the chairmanship of Tom Ban, to document both the history of the College and the enire field. It was co-edited by Ban, David Healy and Edward Shorter. Its publication was supported by the College primarily from non-restricted publication grants received from Pierre Fabre, Janssen Pharmaceutica and Research Foundation,Inc., and Janssen Phamaceutica International in Collaboration with Organon International.
The Rise of Psychopharmacology and the Story of CINP
Author: Thomas A. BanPublisher:
ISBN: 9789634081050
Category : Psychopharmacology
Languages : en
Pages : 448
Book Description
The Triumph of Psychopharmacology and the Story of CINP
Author: Thomas A. BanPublisher:
ISBN: 9789634081814
Category : Psychopharmacology
Languages : en
Pages : 375
Book Description
Reflections on Twentieth-century Psychopharmacology
Author: Thomas A. BanPublisher:
ISBN: 9789639410497
Category : Psychopharmacology
Languages : en
Pages : 720
Book Description
"The story of the 1990s is complemented by reflections on twentieth-century psychopharmacology by the few of those who actively participated throughout the development of the field"--Page 4 of cover.
Thirty Years CINP
Author: Thomas A BanPublisher: Springer Science & Business Media
ISBN: 3642739563
Category : Medical
Languages : en
Pages : 185
Book Description
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952. In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients". The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry. In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func tions. It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.
The Rise and Fall of the Age of Psychopharmacology
Author: Edward ShorterPublisher: Oxford University Press
ISBN: 0197574432
Category : Medical
Languages : en
Pages : 449
Book Description
In The Rise and Fall of the Age of Psychopharmacology, esteemed historian Edward Shorter proposes that the recent history of psychiatry is that of a failed scientific discipline of medicine. Medicine generally is about the story of progress, but psychiatry's story is that of failure in diagnosis, in therapeutics, and in the ability to deliver science-based care to suffering individuals.
History of Psychopharmacology. the Origins of Scientificmedicine: Biological Pillars on the Birth of Psychopharmacology.
Author: Francisco Lopez-MunozPublisher:
ISBN: 9780916182250
Category :
Languages : en
Pages : 600
Book Description
In recent years, with the introduction of new molecules into the arsenal of psychiatric therapy, the historical significance of classical psychotropic drugs to modern society has been lost. Keep in mind that its modern history is very short, born in the 1950s with the introduction of lithium, chlorpromazine, and imipramine, known as the "revolution of psychopharmacology." The purpose of this work it to review how psychoactive substances have been discovered, developed, and applied over the millennia. The text presents the drugs that are used in medicine, their origins, the principles of biological theories of mental disorders, and contribution of basic research.
The Rise and Fall of the Age of Psychopharmacology
Author: Edward ShorterPublisher: Oxford University Press
ISBN: 0197574459
Category : Medical
Languages : en
Pages : 449
Book Description
The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind. But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients. Behind this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.